Last reviewed · How we verify
NCT01986244: TAR1600
Total Ankle Replacement for Ankle Arthritis
trial in Ankle Osteoarthritis in 1,043 participants. Completed in 5 November 2019.
5 November 2019
Quick facts
| Lead sponsor | Duke University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,043 |
| Start date | 13 June 2007 |
| Primary completion | 5 November 2019 |
| Estimated completion | 5 November 2019 |
| Sites | 1 location across United States |
Conditions studied
- Ankle Osteoarthritis — all drugs for Ankle Osteoarthritis →
Sponsor
Duke University
Who can join
18 and older, any sex, with Ankle Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to prospectively evaluate the functional outcome and patient satisfaction of total ankle replacement for tibio-talar osteoarthritis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Patient Risk Factors Do Not Impact 90-Day Readmission and Emergency Department Visitation After Total Ankle Arthroplasty: Implications for the Comprehensive Care for Joint Replacement (CJR) Bundled Payment Plan.
Cunningham D, Karas V, DeOrio J, Nunley J, et al · · 2018 · cited 20× · PMID 30063591 · DOI 10.2106/jbjs.17.01149
Verify or expand the search:
- PubMed search for NCT01986244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ankle Osteoarthritis
Currently open trials in the same condition.
- NCT07417436 — Effects of Graded Motor Imagery in Individuals With Foot/Ankle Osteoarthritis · NA · recruiting
- NCT06404801 — Development of Stance Control Orthotic Knee Joint For Improvement of KAFO Users · active not recruiting
- NCT06525545 — Early MOtion Total Ankle Artroplasty · NA · recruiting
- NCT06193057 — Comparison of Customized and Standard Total Ankle Prostheses · NA · recruiting
- NCT06514196 — Post- Approval Hintermann Series H® Study 1 · active not recruiting
Other Duke University trials
Trials by the same sponsor.
- NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
- NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
- NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
- NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
- NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01986244 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Duke University
- Last refreshed: 6 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01986244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing